Evidence map›Paper›PMID 27062579›Full record

ArticleVirology2016

1918 Influenza receptor binding domain variants bind and replicate in primary human airway cells regardless of receptor specificity.

A Sally Davis, Daniel S Chertow, Jason Kindrachuk, Li Qi, Louis M Schwartzman, Jon Suzich, Sara Alsaaty, Carolea Logun, James H Shelhamer, Jeffery K Taubenberger

Abstract read
In one paragraph

Article in Virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. The 1918 Influenza Pandemic and Its Legacy.Cold Spring Harbor perspectives in medicine · 2020
    Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A Sally DavisViral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States; Diagnostic Medicine and Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan, KS, United States.
Daniel S ChertowViral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States; Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD, United States.
Jason KindrachukCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD, United States.
Li QiViral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States.
Louis M SchwartzmanViral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States.
Jon SuzichViral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States; Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD, United States.
Sara AlsaatyCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD, United States.
Carolea LogunCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD, United States.
James H ShelhamerCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD, United States.
Jeffery K TaubenbergerViral Pathogenesis and Evolution Section, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States. Electronic address: taubenbergerj@niaid.nih.gov.

Funding

Influenza Viral PathogenesisZIAAI000986 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI TAUBENBERGER, JEFFERY · 2009 to 2025
$30.0M
Analysis of Historical Influenza VirusesZIAAI000995 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI TAUBENBERGER, JEFFERY · 2009 to 2017
$4.0M
Intramural NIH HHS ZIA AI000986Intramural NIH HHS ZIA AI000995
6 · The paper itself

Abstract

The 1918 influenza pandemic caused ~50 million deaths. Many questions remain regarding the origin, pathogenicity, and mechanisms of human adaptation of this virus. Avian-adapted influenza A viruses preferentially bind α2,3-linked sialic acids (Sia) while human-adapted viruses preferentially bind α2,6-linked Sia. A change in Sia preference from α2,3 to α2,6 is thought to be a requirement for human adaptation of avian influenza viruses. Autopsy data from 1918 cases, however, suggest that factors other than Sia preference played a role in viral binding and entry to human airway cells. Here, we evaluated binding and entry of five 1918 influenza receptor binding domain variants in a primary human airway cell model along with control avian and human influenza viruses. We observed that all five variants bound and entered cells efficiently and that Sia preference did not predict entry of influenza A virus to primary human airway cells evaluated in this model.

Indexed as

Virus AttachmentBinding SitesBronchiEpithelial CellsInfluenza A Virus, H1N1 SubtypeInfluenza Pandemic, 1918-1919N-Acetylneuraminic AcidReal-Time Polymerase Chain ReactionReceptors, VirusTracheaVirus ReplicationN-Acetylneuraminic AcidReceptors, VirusHemagglutininInfluenza A virusPandemicReceptor binding

Identifiers

PMID27062579
PMCPMC4949484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.